Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.
D000328:Adult; D001741:Black or African American; D000367:Age Factors; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D001799:Blood Sedimentation; D005260:Female; D005500:Follow-Up Studies; D005767:Gastrointestinal Diseases / Q000150:complications; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D007841:Latex Fixation Tests; D008171:Lung Diseases / Q000150:complications; D008297:Male; D008875:Middle Aged; D010414:Pennsylvania; D011928:Raynaud Disease / Q000150:complications; D012595:Scleroderma, Systemic / Q000150:complications / Q000175:diagnosis / Q000401:mortality*; D012737:Sex Factors; D012871:Skin Diseases / Q000150:complications; D013714:Tennessee; D013997:Time Factors; D005719:gamma-Globulins / Q000032:analysis
D000974:Antibodies, Antinuclear; D005719:gamma-Globulins